RICHARD BASSETT: Open Payments
NPI 1265204994 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,543 in 58 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $1,405 · 2025 $1,543
Food & beverage: $1,543
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 17 | $429 |
| Optinose US, Inc. | 13 | $394 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $194 |
| GENZYME CORPORATION | 11 | $181 |
| AstraZeneca Pharmaceuticals LP | 3 | $148 |
| Smith+Nephew, Inc. | 1 | $59 |
| Regeneron Healthcare Solutions, Inc. | 2 | $41 |
| Inspire Medical Systems, Inc. | 1 | $33 |
| Medtronic, Inc. | 2 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
Products named: NUCALA, Xhance, DUPIXENT, NEFFY, TULA, INSPIRE, PROPEL, VIVAER STYLUS.
Industry payments across AZ — which companies pay providers there.
